The identification of a molecular interaction between presenilin 1 (PS1), encoded by the PSEN1 gene, and αSyn was suggested to in part explain the clinical and pathophysiological overlaps between AD and synucleinopathies like DLB [64]. This evidence concerns the gene PSEN1 and synucleinopathy.